AE-87-GP03_0.01uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.01uM, 4-(benzyloxymethyl)-2-(2-chlorophenyl)-5-(pyrazin-2-ylmethyl)-1H-pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione, NADPH Oxidase Inhibitors targeting NOX1, NOX4 (Novartis, 49836406)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/49836406
Similar Terms
Downloads & Tools

Genes

12 genes differentially expressed following the AE-87-GP03_0.01uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
FAU Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed 0.620745
RPL41 ribosomal protein L41 0.477631
VAPA VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa 0.396581
TGM5 transglutaminase 5 0.25036
MRPL52 mitochondrial ribosomal protein L52 0.245546
RPL18A ribosomal protein L18a 0.219763
TNF tumor necrosis factor 0.219763

decreased expression

Symbol Name Standardized Value
CHRAC1 chromatin accessibility complex 1 -0.321499
TAF9 TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 32kDa -0.321499
G6PC3 glucose 6 phosphatase, catalytic, 3 -0.275217
ZNF706 zinc finger protein 706 -0.25036
ITGA3 integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) -0.2165